1. “Personalized oncology : progress and new challenges in HER2 positive breast cancer”
2. “Personalized oncology : progress and new challenges in luminal HER2 negative breast cancer”
3. The urgent need for innovative clinical trial designs in the era of “personalized” oncology

Az előadások 30 percesek, amelyeket 10 perc diszkusszió követ.